Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maestro Health is a technology-driven third-party administrator (TPA) specializing in optimizing health plan management for self-funded employers. It integrates technology, clinical care management, and cost containment services, including a proprietary pharmacy cost containment program, to deliver better health outcomes and lower costs. Acquired by Marpai in November 2022, Maestro Health now strengthens Marpai's AI-enhanced health plan administration platform, continuing its focus on member-centric health benefits and cost-effective solutions for employers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maestro Health.